These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7347707)

  • 21. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combination therapy with ciprofloxacin and azlocillin in intensive care patients with pneumonia and/or sepsis.
    Engelhardt D; Ruckdeschel G
    J Chemother; 1989 Jul; 1(4 Suppl):788-9. PubMed ID: 16312640
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects.
    Levison ME
    Infect Dis Clin North Am; 1995 Sep; 9(3):483-95. PubMed ID: 7490429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of imipenem and meropenem on serum sensitivity and surface hydrophobicity of Klebsiella pneumoniae.
    Hostacká A
    Arzneimittelforschung; 1998 Nov; 48(11):1101-3. PubMed ID: 9850433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The rapid microbiological control of the efficacy of the antibacterial therapy of bacteremia and septicemia].
    Kotliarova GA; Lopatkin NA; Kondrat'eva EM; Perepanova TS
    Urol Nefrol (Mosk); 1997; (3):8-13. PubMed ID: 9245063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of recombinant human activated protein C on the bactericidal activity of human monocytes and modulation of pro-inflammatory cytokines in the presence of antimicrobial agents.
    Baltch AL; Bopp LH; Ritz WJ; Michelsen PB; Yan SB; Um S; Smith RP
    J Antimicrob Chemother; 2007 Jun; 59(6):1177-81. PubMed ID: 17428810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dosage of gentamicin. Microbiological and pharmacological aspects].
    Yourassowsky E
    Schweiz Rundsch Med Prax; 1973 Apr; 62(14):451-3. PubMed ID: 4695879
    [No Abstract]   [Full Text] [Related]  

  • 30. Assay of antibacterial activities of the bactericidal/permeability-increasing protein in natural biological fluids.
    Weiss J
    Methods Mol Biol; 1997; 78():217-31. PubMed ID: 9276307
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
    Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
    Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Septicemia (author's transl)].
    Klastersky J
    Rev Med Brux; 1982 Jun; 3(6):383-92. PubMed ID: 7051221
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis.
    Zeitlinger MA; Erovic BM; Sauermann R; Georgopoulos A; Müller M; Joukhadar C
    J Antimicrob Chemother; 2005 Oct; 56(4):703-8. PubMed ID: 16120628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro testing of antimicrobial agents.
    Woods GL
    Infect Dis Clin North Am; 1995 Sep; 9(3):463-81. PubMed ID: 7490428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bactericidal activity in serum and its prognostic clinical value.
    Klastersky J
    Infection; 1983; 11 Suppl 2():S93-6. PubMed ID: 6368398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.
    Wareham DW; Wilks M; Ahmed D; Brazier JS; Millar M
    Clin Infect Dis; 2005 Apr; 40(7):e67-8. PubMed ID: 15824978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on total serum antibacterial activity tests in the treatment of infectious diseases].
    Saito T
    Iryo; 1969 Jun; 23(6):778-91. PubMed ID: 5821507
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-infective drugs in the prevention and treatment of sepsis syndrome.
    Beam TR
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):275-93. PubMed ID: 7946188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa.
    Pepeljnjak S; Kosalec I
    FEMS Microbiol Lett; 2004 Nov; 240(1):111-6. PubMed ID: 15500987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antibiotics testing and its relationship to clinical activity.
    Mouton Y; Dubreuil L
    J Chemother; 1997 May; 9 Suppl 1():93-9. PubMed ID: 9248967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.